Clinical Trials · NCT02314299
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 20
- Start date
- Nov 2014
- Locations
- 1 site, United States
- Primary endpoint
- Incidence and severity of systemic and ocular adverse events